alpha-Tomatine inactivates PI3K/Akt and ERK signaling pathways in human lung adenocarcinoma A549 cells: Effect on metastasis

作者:Shih Yuan Wei; Shieh Jiunn Min; Wu Pei Fen; Lee Yi Chieh; Chen Yi Zhi; Chiang Tai An*
来源:Food and Chemical Toxicology, 2009, 47(8): 1985-1995.
DOI:10.1016/j.fct.2009.05.011

摘要

This study first investigates the anti-metastastic effect of alpha-tomatine in the human lung adenocarcinoma cell line: A549. In this study, we first noted alpha-tomatine inhibited A549 cells invasion and migration by wound-healing assay and Boyden chamber assay. The data also showed a-tomatine could inhibit phosphorylation of Akt and extracellular signal-regulated kinase I and 2 (ERK1/2), which is involved in the up-regulating matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) or urokinase-type plasminogen activator (u-PA), whereas it did not affect phosphorylation of c-Jun N-terminal kinase (JNK) and p38. Next, alpha-tomatine significantly decreased the nuclear levels of nuclear factor kappa B (NF-kappa B), c-Fos, and c-Jun. Also, treating A549 cells with alpha-tomatine also leads to a dose-dependent inhibition on the binding abilities of NF-kappa B and activator protein-1 (AP-1). Further, the treatment of inhibitors specific for PI3K (Wortmannin) or ERK (U0126) to A549 cells could cause reduced activities of MMP-2, MMP-9, and u-PA. These results showed alpha-tomatine could inhibit the metastatic ability of A549 cells by reducing MMP-2, MMP-9, and u-PA activities through suppressing phosphoinositide 3-kinase/Akt (PI3K/Akt) or ERK1/2 signaling pathway and inhibition NF-kappa B or AP-1 binding activities. These findings proved alpha-tomatine might be an anti-metastastic agent against human lung adenocarcinoma.

  • 出版日期2009-8